In human basophils, the tripeptide KPV did not suppress basophil activation, unlike α-MSH.
In plain wordsIn human blood cells in the lab, KPV did not reduce basophil activation.
- Peptide
- KPV
- Outcome
- No significant changeSuppression of basophil activation
- Study
humann: not reported in source
basophils from human blood- Outcome group
- Immune response · Immune and inflammation
- Studied dose
- Dose not stated
Source sentences
not elicited by the tripeptides KPV and KdPT, both of which lack the central pharmacophore of α-MSH.
1 context sentence(design, population, supporting numbers)
Basophil activity was assessed based on CD63 surface expression and cytokine release.